Business Description
Organon & Co
NAICS : 325412
SIC : 2834
Description
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | -0.08 | |||||
| Debt-to-Equity | -9.99 | |||||
| Debt-to-EBITDA | 5.08 | |||||
| Interest Coverage | 4.04 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.44 | |||||
| Beneish M-Score | -2.33 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.7 | |||||
| 3-Year EBITDA Growth Rate | -24.4 | |||||
| 3-Year EPS without NRI Growth Rate | -34.4 | |||||
| 3-Year FCF Growth Rate | -45.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | -5.06 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.29 | |||||
| 9-Day RSI | 61.2 | |||||
| 14-Day RSI | 49.93 | |||||
| 6-1 Month Momentum % | 4.66 | |||||
| 12-1 Month Momentum % | -29.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.56 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 149.34 | |||||
| Days Sales Outstanding | 84.06 | |||||
| Days Payable | 183.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.77 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| Forward Dividend Yield % | 4.77 | |||||
| 5-Year Yield-on-Cost % | 4.77 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.84 | |||||
| Operating Margin % | 27.62 | |||||
| Net Margin % | 14.85 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 8.6 | |||||
| ROIC % | 18.33 | |||||
| ROC (Joel Greenblatt) % | 92.81 | |||||
| ROCE % | 18.76 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.55 | |||||
| PE Ratio without NRI | 6.55 | |||||
| PS Ratio | 0.93 | |||||
| Price-to-Free-Cash-Flow | 13.97 | |||||
| Price-to-Operating-Cash-Flow | 6.96 | |||||
| EV-to-EBIT | 9.13 | |||||
| EV-to-EBITDA | 8.02 | |||||
| EV-to-Revenue | 2.28 | |||||
| EV-to-FCF | 32.67 | |||||
| Earnings Yield (Greenblatt) % | 10.95 |
How Organon & Co (OGN) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:OGN
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Organon & Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6,174 | ||
| EPS (TTM) ($) | 3.59 | ||
| Beta | 0 | ||
| Volatility % | 40.21 | ||
| 14-Day RSI | 49.93 | ||
| 14-Day ATR ($) | 0.689245 | ||
| 20-Day SMA ($) | 22.506 | ||
| 12-1 Month Momentum % | -29.89 | ||
| 52-Week Range ($) | 20.96 - 39.09 | ||
| Shares Outstanding (Mil) | 254.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Organon & Co Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Organon & Co Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Organon & Co Frequently Asked Questions
What is Organon & Co(OGN)'s stock price today?
The current price of OGN is $23.52. The 52 week high of OGN is $39.09 and 52 week low is $20.96.
When is next earnings date of Organon & Co(OGN)?
The next earnings date of Organon & Co(OGN) is 2023-05-05 Est..
Does Organon & Co(OGN) pay dividends? If so, how much?
The Dividend Yield %  of Organon & Co(OGN) is 4.77% (As of Today), Highest Dividend Payout Ratio of Organon & Co(OGN) was 0.31. The lowest was 0.11. And the median was 0.21. The  Forward Dividend Yield % of Organon & Co(OGN) is 4.77%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
